Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

256.14 +0.32 (+0.13%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About ↗
Things are going well for the pharmaceutical giant. 
Via The Motley Fool
Topics Lawsuit
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
Which dow jones stocks are moving on Thursday? ↗
Via Chartmill
News headline image
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Deals ↗
Johnson & Johnson expands its biotech pipeline with Firefly Bio acquisition and a strategic partnership with Sail Biomedicines. 
Via Benzinga
Johnson & Johnson (NYSE:JNJ) Is a Top Dividend Quality Stock for Reliable Income ↗
Via Chartmill
News headline image
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
From Johnson & Johnson
Via Business Wire
News headline image
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now ↗
But is that performance sustainable? 
Via The Motley Fool
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth ↗
Johnson & Johnson's revenue has grown modestly while Eli Lilly's revenue has nearly doubled in two years, narrowing a once-wide gap. 
Via The Motley Fool
Chips Sell First, Ask Questions Later - And SK Hynix Just Handed Them the Answer ↗
Via Chartmill
News headline image
Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest ↗
Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc litigation over ovarian cancer claims. 
Via Benzinga
News headline image
Stock Market Today: Dow Jones Futures Gain, Nasdaq 100 Declines as Oil Slips Ahead of Trump's Meetings With Zelensky and Netanyahu—Boeing, Coca-Cola, Johnson & Johnson in Focus ↗
U.S. stock futures were mixed on Tuesday, as the Dow Jones index gained but the S&P 500 and Nasdaq 100 indices declined. 
Via Benzinga
Topics Government Stocks
News headline image
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
From Johnson & Johnson
Via Business Wire
News headline image
If I Only Had $500 to Invest, This Is the ETF I'd Buy Right Now ↗
This value ETF offers a great value for investors right now. 
Via The Motley Fool
Topics ETFs Economy
News headline image
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson? ↗
Both have very promising futures. 
Via The Motley Fool
Which dow jones stocks are moving on Friday? ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It ↗
A name that's often ignored by investors due to its limited historic growth is evolving into a solid income-growth prospect. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗
There are plenty of reasons to love these companies. 
Via The Motley Fool
These dow jones stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System ↗
FDA grants De Novo authorization for Johnson & Johnson's OTTAVA robotic surgical system for general surgery procedures. 
Via Benzinga
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
From Johnson & Johnson
Via Business Wire
Which dow jones stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Stay informed with the top movers within the dow jones index on Monday. ↗
Via Chartmill
News headline image
5 Stocks Quietly Trading Near All-Time Highs While Everyone Watches the AI Drama ↗
While AI stocks correct, Johnson & Johnson, Altria, Coca-Cola, JPMorgan, and Apple are quietly trading near 52-week or all-time highs ahead of earnings. 
Via MarketBeat
Topics Artificial Intelligence Initial Public Offering
News headline image
PJP vs. IYH: Which Healthcare ETF Is the Better Buy? ↗
PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend yield. 
Via The Motley Fool
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.